Galena Biopharma (GALE) Research Pioneer Presented With 2014 Award For Excellence In Technology Transfer
4/24/2014 9:19:46 AM
PORTLAND, Ore., April 24, 2014 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced that the 2014 Award for Excellence in Technology Transfer was granted to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) and the Uniformed Services University of the Health Sciences (USU). The award was presented by the Federal Laboratory Consortium for Technology Transfer for work by George Peoples, M.D., chief of surgical oncology at the San Antonio Military Medical Center, and his colleagues, for the licensing of NeuVax™ (nelipepimut-S), a breast cancer vaccine to reduce breast cancer recurrence.
Help employers find you! Check out all the jobs and post your resume.
comments powered by